Evaluation of CD163 expression on alveolar macrophages from BAL of patients with Fibrotic Lung Diseases.
E. Vasarmidi (Heraklion, Greece), E. Bibaki (Heraklion, Greece), C. Koutoulaki (Heraklion, Greece), S. Mastrodemou (Heraklion, Greece), A. Trachalaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), E. Tsitoura (Heraklion, Greece), K. Antoniou (Heraklion, Greece)
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Session: Biomarkers of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 4694
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Vasarmidi (Heraklion, Greece), E. Bibaki (Heraklion, Greece), C. Koutoulaki (Heraklion, Greece), S. Mastrodemou (Heraklion, Greece), A. Trachalaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), E. Tsitoura (Heraklion, Greece), K. Antoniou (Heraklion, Greece). Evaluation of CD163 expression on alveolar macrophages from BAL of patients with Fibrotic Lung Diseases.. 4694
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: